共 11 条
[1]
Kyle R.A., Current concepts on monoclonal gammopathies, Aust NZ J Med, 22, (1992)
[2]
Talerman A., Hije W.G., The frequency of M-components in sera of patients with solid malignant neoplasms, Br J Cancer, 27, (1973)
[3]
Sehgal T., Sharma S., Naseem S., Varma N., Das A., Sharma S.C., Synchronous Occurrence of Prostate Carcinoma and Multiple Myeloma: A Case Report, Indian J Hematol Blood Transfus, 30, pp. 359-362, (2014)
[4]
Huang E., Teh B.S., Saleem A., Butler E.B., Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma, Urology, 60, 6, (2002)
[5]
Kao J., Jani A.B., Vijayakumar S., Is there an association between multiple myeloma and prostate cancer?, Med Hypotheses, 63, 2, pp. 226-231, (2004)
[6]
Niels W.C., Et al., The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: Recommendations from the European Myeloma Network, Haematologica, 99, 6, pp. 984-996, (2014)
[7]
Abdul M., Hoosein N.M., Gammopathy associated with advanced prostate carcinoma, Urol Res, 23, 3, pp. 185-188, (1995)
[8]
Migliore P.J., Alexanian R., Monoclonal gammopathy in human neoplasia, Cancer, 21, 6, pp. 1127-1131, (1968)
[9]
Solomon A., Homogeneous (monoclonal) immunoglobulins in cancer, Am J Med, 63, 2, pp. 169-176, (1977)
[10]
Lsobe T., Osserman E.F., Pathologic conditions associated with plasma cell dyscrasias: A study of 806 cases, Ann N y Acad Sci, 190, (1971)